CoreCivic, Inc. (CXW) is a publicly traded Real Estate sector company. As of May 21, 2026, CXW trades at $21.38 with a market cap of $2.08B and a P/E ratio of 19.64. CXW moved +1.86% today. Year to date, CXW is +9.02%; over the trailing twelve months it is -5.23%. Its 52-week range spans $12.24 to $24.99. Analyst consensus is strong buy with an average price target of $29.33. Rallies surfaces CXW's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
What changed in CXW news today?
CoreCivic Q1 Revenue Up 25.8% to $614.7M, EPS Soars 74%: CoreCivic delivered first-quarter revenue of $614.7 million, up 25.8% year-over-year, with net income rising 51% to $37.9 million and adjusted EPS climbing 73.9% to $0.40. The company activated four previously idle facilities, repurchased 2.3 million shares for $44.7 million and acquired Clinical Solutions Pharmacy to diversify cash flows.
CoreCivic Q1 Revenue Up 25.8% to $614.7M, EPS Soars 74%: CoreCivic delivered first-quarter revenue of $614.7 million, up 25.8% year-over-year, with net income rising 51% to $37.9 million and adjusted EPS climbing 73.9% to $0.40. The company activated four previously idle facilities, repurchased 2.3 million shares for $44.7 million and acquired Clinical Solutions Pharmacy to diversify cash flows.
Does Rallies summarize CXW news?
Yes. Rallies summarizes CXW news with ticker-specific context, catalysts, source links, and AI-generated market summaries when news is available.
Is CXW research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CXW. It does not provide personalized investment advice.
